Doctors Urge Fed. Circ. To Keep Cholesterol Drug On Market
By Kelcee Griffis ( January 25, 2017, 9:06 PM EST) -- Cardiologists and other medical practitioners filed amicus briefs Tuesday urging the Federal Circuit to stop a permanent injunction issued earlier this month that would pull Sanofi's cholesterol-lowering drug Praluent off the market after a jury found Amgen's patents for a competing product are valid....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.